[HTML][HTML] More treatment but no less depression: The treatment-prevalence paradox

J Ormel, SD Hollon, RC Kessler, P Cuijpers… - Clinical psychology …, 2022 - Elsevier
Treatments for depression have improved, and their availability has markedly increased
since the 1980s. Mysteriously the general population prevalence of depression has not …

Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta‐analysis

TA Furukawa, K Shinohara, E Sahker… - World …, 2021 - Wiley Online Library
Major depression is often a relapsing disorder. It is therefore important to start its treatment
with therapies that maximize the chance of not only getting the patients well but also keeping …

[HTML][HTML] Maintenance or discontinuation of antidepressants in primary care

G Lewis, L Marston, L Duffy, N Freemantle… - … England Journal of …, 2021 - Mass Medical Soc
Background Patients with depression who are treated in primary care practices may receive
antidepressants for prolonged periods. Data are limited on the effects of maintaining or …

[HTML][HTML] Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of …

W Kuyken, R Hayes, B Barrett, R Byng, T Dalgleish… - The Lancet, 2015 - thelancet.com
Background Individuals with a history of recurrent depression have a high risk of repeated
depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the …

Neuromodulators for functional gastrointestinal disorders (disorders of gut− brain interaction): a Rome foundation working team report

DA Drossman, J Tack, AC Ford, E Szigethy… - Gastroenterology, 2018 - Elsevier
Background & Aims Central neuromodulators (antidepressants, antipsychotics, and other
central nervous system− targeted medications) are increasingly used for treatment of …

[图书][B] Deadly medicines and organised crime: how big pharma has corrupted healthcare

P Gotzsche - 2019 - taylorfrancis.com
PRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART
DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the …

When to consider electroconvulsive therapy (ECT).

CH Kellner, J Obbels… - Acta Psychiatrica …, 2020 - search.ebscohost.com
Objective: To familiarize the reader with the role of electroconvulsive therapy (ECT) in
current psychiatric medicine. Method: We review clinical indications for ECT, patient …

Antibacterial activity and synergistic antibacterial potential of biosynthesized silver nanoparticles against foodborne pathogenic bacteria along with its anticandidal …

JK Patra, KH Baek - Frontiers in microbiology, 2017 - frontiersin.org
Silver nanoparticles plays a vital role in the development of new antimicrobial substances
against a number of pathogenic microorganisms. These nanoparticles due to their smaller …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute …

M Bauer, A Pfennig, E Severus… - The world journal of …, 2013 - Taylor & Francis
Objectives. This 2013 update of the practice guidelines for the biological treatment of
unipolar depressive disorders was developed by an international Task Force of the World …

Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology

GM Goodwin, PM Haddad, IN Ferrier… - Journal of …, 2016 - journals.sagepub.com
The British Association for Psychopharmacology guidelines specify the scope and targets of
treatment for bipolar disorder. The third version is based explicitly on the available evidence …